Cargando…

The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab

To seek the cutoff value of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) that is necessary to achieve remission under the new Boolean-based criteria, we analyzed the data for 285 patients with rheumatoid arthritis registered between May 2008 and November 2009...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirabayashi, Yasuhiko, Ishii, Tomonori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558670/ https://www.ncbi.nlm.nih.gov/pubmed/23090655 http://dx.doi.org/10.1007/s10067-012-2103-4

Ejemplares similares

DAS28‐CRP Cutoffs for High Disease Activity and Remission Are Lower Than DAS28‐ESR in Rheumatoid Arthritis
por: Greenmyer, Jacob R., et al.
Publicado: (2020)

Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study
por: Lee, Yvonne C, et al.
Publicado: (2011)

Response to 'Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study'
por: Yoshida, Kazuki, et al.
Publicado: (2011)

Performance of the new 2011 ACR/EULAR remission criteria with tocilizumab using the phase IIIb study TAMARA as an example and their comparison with traditional remission criteria
por: Iking-Konert, Christof, et al.
Publicado: (2011)

A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis
por: Janke, Kirsten, et al.
Publicado: (2022)

Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort
por: Sewerin, Philipp, et al.
Publicado: (2017)

Time to achieve remission determines time to be in remission
por: Schipper, Lydia G, et al.
Publicado: (2010)

DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable
por: Fleischmann, Roy M, et al.
Publicado: (2017)

Discrepancies in assessment of patients with rheumatoid arthritis and secondary Sjögren's syndrome by DAS28-ESR and DAS28-CRP
por: Romanowska-Próchnicka, Katarzyna, et al.
Publicado: (2016)

Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab
por: Hirata, Shintaro, et al.
Publicado: (2015)

Validity and risk of adopting PGA ≤ 2 as a remission criteria of Boolean in clinical practice in patient with rheumatoid arthritis
por: Yoshii, Ichiro, et al.
Publicado: (2022)

Tocilizumab for faster and safer remission of Takayasu’s arteritis
por: Liao, Hua, et al.
Publicado: (2022)

Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritis
por: Hamann, Philip D H, et al.
Publicado: (2019)

Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice
por: Hirabayashi, Yasuhiko, et al.
Publicado: (2009)

Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study
por: Paulshus Sundlisæter, Nina, et al.
Publicado: (2022)

Proposed criteria for schizophrenia remission
por: AlAqeel, Bandar
Publicado: (2014)

Validity of Remission Criteria in Rheumatoid Arthritis Compared to Ultrasound-Defined Remission
por: Ben Abdelghani, Kawther, et al.
Publicado: (2022)

Utility of remission criteria for the renal prognosis of IgA nephropathy
por: Matsuzaki, Keiichi, et al.
Publicado: (2021)

Comparative Efficacy (DAS28 Remission) of Targeted Immune Modulators for Rheumatoid Arthritis: A Network Meta-Analysis
por: Best, Jennie H., et al.
Publicado: (2021)

Harmonizing Medicine and Surgery in the Pursuit of Boolean Remission: A Rheumatological Magnum Opus
por: Rehman, Abdur, et al.
Publicado: (2023)

Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients?
por: Ten Cate, D. F., et al.
Publicado: (2018)

Predicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: Model Derivation and Remission Score Development
por: Collins, Jamie E., et al.
Publicado: (2020)

Sustained remission of Multicentric Castleman Disease in children treated with tocilizumab
por: Galeotti, C, et al.
Publicado: (2011)

Dramatic radiographic repair by tocilizumab in a very elderly patient with rheumatoid arthritis
por: Watanabe, Ryu, et al.
Publicado: (2014)

Towards achieving remission in the treatment of depression
por: Mendlewicz, Julien
Publicado: (2008)

Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis
por: Verstappen, M., et al.
Publicado: (2020)

Use of rheumatoid arthritis impact of disease (RAID) in routine care; identification of DAS28 remission and unmet patient-reported outcomes
por: Mistry, Jatin, et al.
Publicado: (2020)

The Utility and Limitations of CRP, ESR and DAS28-CRP in Appraising Disease Activity in Rheumatoid Arthritis
por: Orr, Carl K., et al.
Publicado: (2018)

Asthma remission: what is it and how can it be achieved?
por: Thomas, Dennis, et al.
Publicado: (2022)

Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria
por: Svensson, Björn, et al.
Publicado: (2013)

Brief Report: Remission Rates With Tofacitinib Treatment in Rheumatoid Arthritis: A Comparison of Various Remission Criteria
por: Smolen, Josef S., et al.
Publicado: (2017)

Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition
por: Schoels, M., et al.
Publicado: (2017)

Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis
por: Bugatti, Serena, et al.
Publicado: (2021)

Accuracy of preliminary remission criteria some JIA category
por: Fantini, F, et al.
Publicado: (2008)

Systematic review of histological remission criteria in eosinophilic esophagitis
por: Eke, Ransome, et al.
Publicado: (2018)

Achievement of remission after first-episode psychosis in youth
por: Kaleda, V., et al.
Publicado: (2021)

Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study
por: Saragoussi, Delphine, et al.
Publicado: (2017)

Rheumatoid arthritis patients with predominantly tender joints rarely achieve clinical remission despite being in ultrasound remission
por: Hammer, Hilde Berner, et al.
Publicado: (2021)

The impact of time length to Boolean remission for tight disease activity control after acquisition in rheumatoid arthritis patients
por: Yoshii, Ichiro, et al.
Publicado: (2023)

Serum Infliximab Cutoff trough Level Values for Maintaining Hematological Remission in Pediatric Inflammatory Bowel Disease
por: Choi, So Yoon, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jjmvrj82s4ueht5n37brnpfk0b